Precision Biosciences (DTIL) Capital Expenditures Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 143.40% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | -71.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.88% |
| Dec 31, 2025 | -80.41% |
| Jun 30, 2025 | -92.86% |
| Mar 31, 2025 | -25.58% |
| Dec 31, 2024 | 473.08% |
| Sep 30, 2024 | -89.90% |
| Jun 30, 2024 | -97.40% |
| Mar 31, 2024 | -83.49% |
| Dec 31, 2023 | -104.11% |
| Sep 30, 2023 | -64.59% |
| Jun 30, 2023 | 38.13% |
| Mar 31, 2023 | -36.31% |
| Dec 31, 2022 | -58.01% |
| Sep 30, 2022 | 48.70% |
| Jun 30, 2022 | -53.91% |
| Mar 31, 2022 | -27.29% |
| Dec 31, 2021 | 37.32% |
| Sep 30, 2021 | -29.99% |
| Jun 30, 2021 | -5.32% |
| Mar 31, 2021 | 1.99% |
| Dec 31, 2020 | -80.18% |
| Sep 30, 2020 | -82.31% |
| Jun 30, 2020 | -78.06% |
| Mar 31, 2020 | -78.30% |
| Dec 31, 2019 | -43.99% |
| Sep 30, 2019 | 122.48% |
| Jun 30, 2019 | 621.37% |
| Mar 31, 2019 | 721.00% |